BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 21199182)

  • 1. Non-anti-MAG DADS neuropathy as a variant of CIDP: clinical, electrophysiological, laboratory features and response to treatment in 10 cases.
    Larue S; Bombelli F; Viala K; Neil J; Maisonobe T; Bouche P; Musset L; Fournier E; Léger JM
    Eur J Neurol; 2011 Jun; 18(6):899-905. PubMed ID: 21199182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of Polyneuropathy Associated with Anti-MAG Antibodies.
    Magy L; Kaboré R; Mathis S; Lebeau P; Ghorab K; Caudie C; Vallat JM
    J Immunol Res; 2015; 2015():450391. PubMed ID: 26065001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and laboratory features of anti-MAG neuropathy without monoclonal gammopathy.
    Pascual-Goñi E; Martín-Aguilar L; Lleixà C; Martínez-Martínez L; Simón-Talero MJ; Díaz-Manera J; Cortés-Vicente E; Rojas-García R; Moga E; Juárez C; Illa I; Querol L
    Sci Rep; 2019 Apr; 9(1):6155. PubMed ID: 30992531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nerve ultrasound findings in neuropathy associated with anti-myelin-associated glycoprotein antibodies.
    Lucchetta M; Padua L; Granata G; Luigetti M; Campagnolo M; Dalla Torre C; Coraci D; Sabatelli M; Briani C
    Eur J Neurol; 2015 Jan; 22(1):193-202. PubMed ID: 25174585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, electrophysiological and immunological study of peripheral nerves in Egyptian patients with monoclonal gammopathies.
    El-Difrawy MM; Zaki NE; Marouf HM; Ayad MW; Farag AM
    Int J Hematol; 2012 Jan; 95(1):71-6. PubMed ID: 22193843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Polyneuropathy involving cranial nerves associated with monoclonal IgM antibodies with anti-MAG/SGPG/SGPLG/sulfatides activity].
    Drouet A; Caudie C; Vallat JM; Ruel JH; Felten D; Guilloton L; Giraud P
    Rev Neurol (Paris); 2006 Jun; 162(6-7):760-6. PubMed ID: 16840988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial.
    Gorson KC; Natarajan N; Ropper AH; Weinstein R
    Muscle Nerve; 2007 Jan; 35(1):66-9. PubMed ID: 16967492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential diagnosis of chronic dysimmune demyelinating polyneuropathies with and without anti-MAG antibodies.
    Isoardo G; Migliaretti G; Ciaramitaro P; Rota E; Poglio F; Tavella A; Paolasso I; Cavallo F; Bergamasco B; Cocito D
    Muscle Nerve; 2005 Jan; 31(1):52-8. PubMed ID: 15536620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terminal latency index in polyneuropathy with IgM paraproteinemia and anti-MAG antibody.
    Cocito D; Isoardo G; Ciaramitaro P; Migliaretti G; Pipieri A; Barbero P; Cucci A; Durelli L
    Muscle Nerve; 2001 Oct; 24(10):1278-82. PubMed ID: 11562906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of immune-mediated, dysimmune neuropathies.
    Finsterer J
    Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.
    Lunn MP; Nobile-Orazio E
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD002827. PubMed ID: 27701752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can electrophysiology differentiate polyneuropathy with anti-MAG/SGPG antibodies from chronic inflammatory demyelinating polyneuropathy?
    Capasso M; Torrieri F; Di Muzio A; De Angelis MV; Lugaresi A; Uncini A
    Clin Neurophysiol; 2002 Mar; 113(3):346-53. PubMed ID: 11897535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-SGPG antibody in CIDP: nosological position of IgM anti-MAG/SGPG antibody-associated neuropathy.
    Tagawa Y; Yuki N; Hirata K
    Muscle Nerve; 2000 Jun; 23(6):895-9. PubMed ID: 10842265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A diagnostic score for anti-myelin-associated-glycoprotein neuropathy or chronic inflammatory demyelinating polyradiculoneuropathy in patients with anti-myelin-associated-glycoprotein antibody.
    Doneddu PE; Ruiz M; Bianchi E; Liberatore G; Manganelli F; Cocito D; Cosentino G; Benedetti L; Marfia GA; Filosto M; Briani C; Giannotta C; Nobile-Orazio E
    Eur J Neurol; 2023 Feb; 30(2):501-510. PubMed ID: 35191144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distal acquired demyelinating symmetric neuropathy associated with anti-GM1 antibodies: is this a CIDP variant?
    Remiche G; Kentos A; Mavroudakis N
    Acta Neurol Belg; 2010 Mar; 110(1):103-6. PubMed ID: 20514936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current treatments of chronic immune-mediated demyelinating polyneuropathies.
    Brannagan TH
    Muscle Nerve; 2009 May; 39(5):563-78. PubMed ID: 19301378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of patients with refractory chronic inflammatory demyelinating polyneuropathy.
    Kaplan A; Brannagan TH
    Muscle Nerve; 2017 Apr; 55(4):476-482. PubMed ID: 27463215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go.
    Nobile-Orazio E
    J Peripher Nerv Syst; 2014 Mar; 19(1):2-13. PubMed ID: 24612201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and treatment of chronic acquired demyelinating polyneuropathies.
    Latov N
    Nat Rev Neurol; 2014 Aug; 10(8):435-46. PubMed ID: 24980070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy.
    Kuijf ML; Eurelings M; Tio-Gillen AP; van Doorn PA; van den Berg LH; Hooijkaas H; Stork J; Notermans NC; Jacobs BC
    Neurology; 2009 Sep; 73(9):688-95. PubMed ID: 19720975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.